Allogene Therapeutics (ALLO) Q4 2022 Earnings

28FebConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.7
-0.64
-0.58
-0.52

Details

Expected EPS
-0.7
Actual EPS
-0.66
Surprise EPS
0.04
Surprise Percent
+5.71%

Description

Allogene Therapeutics (ALLO) has reported earnings of -0.66 per share for Q4 2022.

0 Comments

Share your thoughts